Addition of Ruxolitinb to Corticosteroids As First-Line Therapy for High-Risk Acute Graft Versus Host Disease in Allogeneic Peripheral Blood Stem Cell Transplantation
- Resource Type
- Abstract
- Source
- In
Blood 15 November 2022 140 Supplement 1:1381-1382 - Subject
- Language
- ISSN
- 0006-4971